TEX55

gene
On this page

Also known as FLJ32859TSCPA

Summary

TEX55 (testis expressed 55, HGNC:26553) is a protein-coding gene on chromosome 3q13.32, encoding Testis-specific expressed protein 55 (Q96M34).

Located in sperm flagellum.

Source: NCBI Gene 152405 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 9 total
  • MANE Select transcript: NM_152539

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26553
Approved symbolTEX55
Nametestis expressed 55
Location3q13.32
Locus typegene with protein product
StatusApproved
AliasesFLJ32859, TSCPA
Ensembl geneENSG00000163424
Ensembl biotypeprotein_coding
Entrez152405

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay

ENST00000295622, ENST00000460150, ENST00000473121, ENST00000492792, ENST00000494105

RefSeq mRNA: 1 — MANE Select: NM_152539 NM_152539

CCDS: CCDS2984

Canonical transcript exons

ENST00000295622 — 3 exons

ExonStartEnd
ENSE00001074350119151224119151456
ENSE00001074351119146165119147587
ENSE00003631311119148180119148323

Expression profiles

Bgee: expression breadth broad, 26 present calls, max score 95.22.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1069 / max 81.1953, expressed in 5 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
380720.07535
380710.03163

Top tissues by expression

91 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453395.22gold quality
right testisUBERON:000453495.18gold quality
testisUBERON:000047394.88gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.55gold quality
olfactory segment of nasal mucosaUBERON:000538649.90gold quality
bone marrow cellCL:000209241.22gold quality
ventricular zoneUBERON:000305341.12gold quality
colonic epitheliumUBERON:000039737.20gold quality
skeletal muscle tissueUBERON:000113436.85gold quality
calcaneal tendonUBERON:000370136.74gold quality
cortical plateUBERON:000534336.47gold quality
mucosa of transverse colonUBERON:000499136.45gold quality
hindlimb stylopod muscleUBERON:000425236.15silver quality
granulocyteCL:000009436.01gold quality
endometriumUBERON:000129535.94gold quality
adult mammalian kidneyUBERON:000008235.76gold quality
ganglionic eminenceUBERON:000402335.49gold quality
kidneyUBERON:000211334.33gold quality
bone marrowUBERON:000237134.33gold quality
muscle tissueUBERON:000238533.61gold quality
corpus callosumUBERON:000233633.08gold quality
placentaUBERON:000198732.51gold quality
right uterine tubeUBERON:000130231.70gold quality
leukocyteCL:000073831.02gold quality
descending thoracic aortaUBERON:000234530.85gold quality
monocyteCL:000057630.77gold quality
tonsilUBERON:000237230.73gold quality
bloodUBERON:000017830.06gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.58gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.28

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

22 targeting TEX55, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-95-5P99.8972.173973
HSA-MIR-430799.8270.453374
HSA-MIR-4677-5P99.7070.091940
HSA-MIR-128499.6773.561353
HSA-MIR-7156-5P99.6468.811369
HSA-MIR-56799.6368.571219
HSA-MIR-312399.4767.152693
HSA-MIR-127699.3668.181642
HSA-MIR-4999-5P99.3569.15926
HSA-MIR-431199.3170.473041
HSA-MIR-6739-3P99.2268.841843
HSA-MIR-58398.7167.441791
HSA-MIR-1537-5P98.7068.33999
HSA-MIR-471898.5568.61814
HSA-MIR-4790-3P96.6367.08806

Literature-anchored findings (GeneRIF, showing 1)

  • TSCPA was expressed specifically in mouse and human testis and might play an important role in spermatogenesis. (PMID:19821082)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusTex55ENSMUSG00000022798
rattus_norvegicusTex55ENSRNOG00000042555

Paralogs (1): EFCAB10 (ENSG00000185055)

Protein

Protein identifiers

Testis-specific expressed protein 55Q96M34 (reviewed: Q96M34)

Alternative names: Testis-specific conserved, cAMP-dependent type II PK-anchoring protein

All UniProt accessions (5): Q96M34, H7C4V1, H7C564, H7C5E0, S4R404

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus. Cell projection. Cilium. Flagellum.

Tissue specificity. Testis-specific.

RefSeq proteins (1): NP_689752* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR040760Tex55Family
IPR048377TEX55_DDDomain

Pfam: PF17819

UniProt features (18 total): compositionally biased region 9, sequence variant 6, region of interest 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96M34-F148.940.08

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 21 (showing top): GSE45365_NK_CELL_VS_CD8A_DC_DN, GOCC_MOTILE_CILIUM, GOCC_CILIUM, GOCC_9PLUS2_MOTILE_CILIUM, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, MIR4307, MIR4311, MIR4677_5P, MIR3123, MIR4999_5P, MIR4790_3P, chr3q13, PAX6_TARGET_GENES, GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN, GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): nucleus (GO:0005634), sperm flagellum (GO:0036126), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
intracellular membrane-bounded organelle1
9+2 motile cilium1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
cilium1
cellular anatomical structure1

Protein interactions and networks

STRING

216 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TEX55PRSS54Q6PEW0643
TEX55EFCAB10A6NFE3626
TEX55GOLGA6L6A8MZA4602
TEX55SPMIP9Q96LM6585
TEX55CATIPQ7Z7H3582
TEX55ROPN1BQ9BZX4570
TEX55PRSS55Q6UWB4549
TEX55RIIAD1A6NNX1529
TEX55TPGS1Q6ZTW0527
TEX55C8orf34Q49A92506
TEX55GOLGA6L2Q8N9W4506
TEX55FBXL13Q8NEE6454
TEX55AK8Q96MA6446
TEX55ADAM32Q8TC27442
TEX55ADAM21Q9UKJ8433

IntAct

4 interactions, top by confidence:

ABTypeScore
HTTTEX55psi-mi:“MI:0915”(physical association)0.560

BioGRID (2): C3orf30 (Cross-Linking-MS (XL-MS)), C3orf30 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A0P0XCU3, A0A1P8BH59, A1YFC1, A1YGK6, A2T7F2, A6NJ88, B7SY83, F1QU13, F4HXQ7, F4ICX9, F4INW9, F4KCE9, O04251, O81472, O96001, P0CV01, P0CV36, P0CV42, P0CV43, P0CV45, P0CV46, P0CV55, P0CV57, P0CV58, P10322, P16531, P48786, Q0DVU4, Q10P83, Q2EI21, Q3URU2, Q5JY77, Q5QNA6, Q5R7U0, Q5SRN2, Q5U4C1, Q5XPK0, Q6K5K2, Q7T2B3, Q8N3K9

Diamond homologs: A6X8Z9, Q96M34

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

9 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance8
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

340 predictions. Top by Δscore:

VariantEffectΔscore
3:119147588:G:GGdonor_gain0.9900
3:119147583:AATCT:Adonor_gain0.9800
3:119147584:ATCT:Adonor_gain0.9700
3:119159956:G:GGdonor_gain0.9700
3:119147585:TCT:Tdonor_gain0.9600
3:119159955:A:AGdonor_gain0.9600
3:119147477:A:AGdonor_gain0.9400
3:119147478:G:GGdonor_gain0.9400
3:119147586:CT:Cdonor_gain0.9400
3:119151289:AT:Adonor_gain0.9400
3:119147593:T:Gdonor_gain0.9300
3:119147585:TCTGT:Tdonor_loss0.8900
3:119147587:TGTAA:Tdonor_loss0.8900
3:119147588:G:GAdonor_loss0.8900
3:119147589:TA:Tdonor_loss0.8900
3:119147590:AAG:Adonor_loss0.8900
3:119147591:AGTTA:Adonor_loss0.8900
3:119147592:G:Tdonor_loss0.8900
3:119147586:CTGT:Cdonor_loss0.8700
3:119147587:TGTA:Tdonor_loss0.8700
3:119147589:T:TGdonor_loss0.8700
3:119147590:AAGT:Adonor_loss0.8700
3:119147482:C:Gdonor_gain0.8300
3:119147575:A:AGdonor_gain0.8300
3:119147576:G:GGdonor_gain0.8300
3:119148254:A:AGacceptor_gain0.7900
3:119148255:G:GGacceptor_gain0.7900
3:119150186:A:AGacceptor_gain0.7400
3:119150187:A:Gacceptor_gain0.7000
3:119146312:G:GTdonor_gain0.6900

AlphaMissense

3553 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:119148318:T:CF513L0.995
3:119148320:C:AF513L0.995
3:119148320:C:GF513L0.995
3:119151272:T:CF531L0.995
3:119151274:T:AF531L0.995
3:119151274:T:GF531L0.995
3:119148283:T:CL501P0.991
3:119148319:T:CF513S0.991
3:119151240:T:CL520S0.991
3:119151267:T:CL529P0.990
3:119148300:C:GH507D0.986
3:119148319:T:GF513C0.986
3:119148301:A:CH507P0.985
3:119148307:T:CI509T0.985
3:119151276:T:GM532R0.985
3:119151279:T:CL533P0.985
3:119148310:T:CL510P0.984
3:119151228:T:GI516S0.983
3:119151243:T:AV521D0.982
3:119151273:T:CF531S0.982
3:119148307:T:GI509S0.981
3:119151228:T:CI516T0.981
3:119151276:T:CM532T0.981
3:119151276:T:AM532K0.980
3:119148288:T:GY503D0.979
3:119148289:A:CY503S0.979
3:119148265:A:GD495G0.977
3:119148270:T:GY497D0.976
3:119148307:T:AI509N0.976
3:119151264:C:AP528H0.976

dbSNP variants (sampled 300 via entrez): RS1000892004 (3:119151167 C>A,G), RS1001376912 (3:119145615 T>C), RS1002524184 (3:119144688 TA>T,TAA), RS1002660393 (3:119151075 C>T), RS1003312681 (3:119147908 C>T), RS1003343776 (3:119147598 T>C), RS1003694840 (3:119148873 A>G), RS1004706235 (3:119145569 G>C), RS1004792538 (3:119145348 C>T), RS10049288 (3:119146065 G>A,T), RS1005081635 (3:119145743 G>A), RS1005460771 (3:119147956 A>G), RS1005760380 (3:119148259 A>G), RS1006350518 (3:119146901 C>T), RS1006790053 (3:119149129 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST007643_2Gemcitabine-induced early high-grade neutropenia in pancreatic cancer5.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratrolaffects cotreatment, decreases expression1
Arsenicaffects methylation1
Benzo(a)pyrenedecreases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Tobacco Smoke Pollutionincreases expression1
Valproic Acidincreases methylation1
Aflatoxin B1increases methylation1
Permethrindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): neutropenia